Advertisement
Screener

CHINA BCT PHARMACY GROUP, INC. Increase (Decrease) in Accounts Payable, Trade

CHINA BCT PHARMACY GROUP, INC. Increase (Decrease) in Accounts Payable, Trade

CHINA BCT PHARMACY GROUP, INC. reported Increase (Decrease) in Accounts Payable, Trade of $10.67 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2013-05-20

  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in accounts payable, trade for the quarter ending 2013-03-31 was $10.67M, a 47.14% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in accounts payable, trade for the quarter ending 2012-12-31 was -$5.99M, a 213.77% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in accounts payable, trade for the quarter ending 2012-09-30 was -$7.54M.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in accounts payable, trade for the quarter ending 2012-06-30 was -$9.49M, a 171.60% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in accounts payable, trade for fiscal 2012 was -$2.84M, a 128.02% decline from fiscal 2011.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in accounts payable, trade for fiscal 2011 was $10.13M, a 34.08% decline from fiscal 2010.
  • CHINA BCT PHARMACY GROUP, INC. increase (decrease) in accounts payable, trade for fiscal 2010 was $15.37M.
Period endIncrease (Decrease) in Accounts Payable, Trade 3 monthIncrease (Decrease) in Accounts Payable, Trade 6 monthIncrease (Decrease) in Accounts Payable, Trade 9 monthIncrease (Decrease) in Accounts Payable, Trade 12 month
2013-03-31$10.67M
10-Q · filed 2013-05-20
$4.68M
derived: sum of 2 quarters · filed 2013-05-20
-$2.86M
derived: sum of 3 quarters · filed 2013-05-20
-$12.36M
derived: sum of 4 quarters · filed 2013-05-20
2012-12-31-$5.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
-$13.54M
derived: sum of 2 quarters · filed 2013-04-15
-$23.03M
derived: sum of 3 quarters · filed 2013-04-15
-$2.84M
10-K · filed 2013-04-15
2012-09-30-$7.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
-$17.04M
derived: sum of 2 quarters · filed 2012-11-15
$3.15M
10-Q · filed 2012-11-15
$8.42M
derived: sum of 4 quarters · filed 2013-05-20
2012-06-30-$9.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$10.70M
10-Q · filed 2012-08-17
$15.96M
derived: sum of 3 quarters · filed 2013-05-20
$10.09M
derived: sum of 4 quarters · filed 2013-05-20
2012-03-31$20.19M
10-Q · filed 2013-05-20
$25.46M
derived: sum of 2 quarters · filed 2013-05-20
$19.59M
derived: sum of 3 quarters · filed 2013-05-20
$32.85M
derived: sum of 4 quarters · filed 2013-05-20
2011-12-31$5.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
-$603.45K
derived: sum of 2 quarters · filed 2013-04-15
$12.66M
derived: sum of 3 quarters · filed 2013-04-15
$10.13M
10-K · filed 2013-04-15
2011-09-30-$5.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
$7.39M
derived: sum of 2 quarters · filed 2012-11-15
$4.86M
10-Q · filed 2012-11-15
$7.74M
derived: sum of 4 quarters · filed 2012-11-15
2011-06-30$13.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$10.73M
10-Q · filed 2012-08-17
$13.61M
derived: sum of 3 quarters · filed 2012-08-17
$16.98M
derived: sum of 4 quarters · filed 2012-08-17
2011-03-31-$2.53M
10-Q · filed 2012-05-21
$353.04K
derived: sum of 2 quarters · filed 2012-06-12
$3.72M
derived: sum of 3 quarters · filed 2012-06-12
2010-12-31$2.88M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12
$6.25M
derived: sum of 2 quarters · filed 2012-06-12
$15.37M
10-K/A · filed 2012-06-12
2010-09-30$3.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$12.48M
10-Q · filed 2011-11-14
2010-06-30$9.12M
10-Q · filed 2011-08-15